Cover Image
市場調查報告書

兒童癲癇:全球臨床實驗趨勢

Childhood Epilepsy Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 349792
出版日期 內容資訊 英文 132 Pages
訂單完成後即時交付
價格
Back to Top
兒童癲癇:全球臨床實驗趨勢 Childhood Epilepsy Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 132 Pages
簡介

本報告提供兒童癲癇治療藥相關之臨床實驗趨勢調查,提供您臨床實驗數量及受驗人數,各階段狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上兒童癲癇的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上兒童癲癇的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

兒童癲癇治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4272CTIDB

GlobalData's clinical trial report, "Childhood Epilepsy Global Clinical Trials Review, H1, 2017" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Childhood Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Childhood Epilepsy Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Childhood Epilepsy 30
  • May 05, 2017: Esperite, The Cell Factory demonstrate antiinflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy 30
  • Apr 19, 2017: Sunovion to Present Data on Aptiom (eslicarbazepine acetate) at the American Academy of Neurology 2017 Annual Meeting 31
  • Clinical Trial Profile Snapshots 32

Appendix 130

  • Abbreviations 130
  • Definitions 130
  • Research Methodology 131
  • Secondary Research 131
  • About GlobalData 132
  • Contact Us 132
  • Source 132

List of Tables

List of Tables

  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Childhood Epilepsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Childhood Epilepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Childhood Epilepsy Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Childhood Epilepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
  • Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Childhood Epilepsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Childhood Epilepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Childhood Epilepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Childhood Epilepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Childhood Epilepsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Childhood Epilepsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
  • Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Childhood Epilepsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Childhood Epilepsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Childhood Epilepsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Childhood Epilepsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 131
Back to Top